Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Ribera Salud sheds half of its management team at Alzira hospital

Ribera Salud has reduced from 22 to 13 the number of directors in Hospital de la Ribera, Alzira, in the Spanish region of Valencia. Trade unions say they were forced to report on the issue due to increasing unrest among workers. They estimate that shareholders Centene and Sabadell will be sparing “a million euros” in management payrolls.

Newly branded Avivo Group plans $300m expansion across five Gulf countries and 2017 London IPO

Pan-Gulf expansion could be the new business model for big private operators. We talk to Amitava Ghosal, the CEO of Avivo, the new name for Healthcare Mena, the operator backed by private equity house Al Masah Capital about his plans. He wants to expand out of the UAE and Kuwait and into Qatar, Oman and Saudi Arabia with a specialist outpatient clinic chain. Future steps include hospitals and SE Asia.

Eurofins could lose tens of millions of revenue

Having taken control of reference lab Biomnis, Eurofins, the fast-growing, listed international lab group, is waving a massive peace sign at other diagnostic lab players in France with the suggestion that they could “co-invest” in the groups. But will they go along with this? Or is Eurofins likely to lose a huge slab of sales?

Report: All listed healthcare service companies active in Emerging Markets

Here we present the first comprehensive list of all 57 quoted healthcare service companies which are active in Emerging Markets. The list includes companies headquartered in the Developed World, who have interests in Emerging Markets, such as Air Liquide, Fresenius or Ramsay Health Care, as well as quoted operators from the region, such as IHH, Apollo or Integrated Diagnostic Holdings. It covers everyone from Chilean hospitals to Egyptian lab operators and from NYSE quoted operators in China to big groups in Malaysia and Indonesia.

Can regional lab chains compete against reference labs in France?

With large reference labs like Cerba and Novescia buying up their own clients, regional chains have started to fight back by creating national groups with central sites for testing. But they are facing many challenges, as competition is fierce and other medical sectors are consolidating.

Bid rumours

Which big lab group is up for sale? And which hospital chain has just been withdrawn after a failed auction? We report! Why not subscribe and find out?

Find Us